Knight Therapeutics Inc. (TSX:GUD)
5.89
+0.02 (0.34%)
Oct 9, 2025, 4:00 PM EDT
Knight Therapeutics Revenue
Knight Therapeutics had revenue of 107.36M CAD in the quarter ending June 30, 2025, with 12.33% growth. This brings the company's revenue in the last twelve months to 384.56M, up 13.82% year-over-year. In the year 2024, Knight Therapeutics had annual revenue of 371.30M with 13.13% growth.
Revenue (ttm)
384.56M
Revenue Growth
+13.82%
P/S Ratio
1.53
Revenue / Employee
516.19K
Employees
745
Market Cap
586.96M
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2024 | 371.30M | 43.11M | 13.13% |
Dec 31, 2023 | 328.20M | 34.64M | 11.80% |
Dec 31, 2022 | 293.56M | 50.09M | 20.57% |
Dec 31, 2021 | 243.48M | 43.96M | 22.03% |
Dec 31, 2020 | 199.52M | 152.06M | 320.39% |
Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
Curaleaf Holdings | 1.75B |
Green Thumb Industries | 1.57B |
Trulieve Cannabis | 1.62B |
dentalcorp Holdings | 1.62B |
Sienna Senior Living | 929.68M |
WELL Health Technologies | 1.12B |
Cronos Group | 177.69M |
Extendicare | 1.51B |
Knight Therapeutics News
- 2 days ago - Knight Therapeutics Announces Relaunch of MYFEMBREE® in Canada - GlobeNewsWire
- 2 days ago - Knight Therapeutics Announces Relaunch of ORGOVYX® in Canada - GlobeNewsWire
- 13 days ago - Knight Therapeutics Inc. places No. 384 on The Globe and Mail’s seventh annual ranking of Canada’s Top Growing Companies - Financial Post
- 13 days ago - Knight Therapeutics Inc. places No. 384 on The Globe and Mail's seventh annual ranking of Canada's Top Growing Companies - GlobeNewsWire
- 7 weeks ago - Knight Therapeutics announces share buyback plan - Seeking Alpha
- 7 weeks ago - Knight Announces Normal Course Issuer Bid - GlobeNewsWire
- 2 months ago - Knight Therapeutics Inc. (KHTRF) Q2 2025 Earnings Call Transcript - Seeking Alpha
- 2 months ago - Knight Therapeutics Reports Second Quarter 2025 Results - GlobeNewsWire